Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation1
J Immunol (2004) 173 (10): 5923–5928.
Currently there are no citedby results. Try again later.
